We are live on ! Find out more
KAS

Kestra Advisory Services Portfolio holdings

AUM $31B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
-4.75%
1 Year Est. Return
+28.39%
3 Year Est. Return
+85.12%
5 Year Est. Return
+94.26%
10 Year Est. Return
AUM
$9.34B
AUM Growth
-$388M
Cap. Flow
+$138M
Cap. Flow %
1.47%
Top 10 Hldgs %
16.39%
Holding
2,284
New
156
Increased
1,074
Reduced
823
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 5.73%
3 Healthcare 5.52%
4 Consumer Discretionary 4.4%
5 Industrials 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMDI
2076
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$14K ﹤0.01%
31,295
+7,030
+29% +$3.65K
FRSX
2077
Foresight Autonomous Holdings
FRSX
$3.73M
$13K ﹤0.01%
202
SEEL
2078
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$13K ﹤0.01%
+3
New +$11.8K
LVO icon
2079
LiveOne
LVO
$61.3M
$11K ﹤0.01%
+1,600
New +$16.9K
TONX
2080
TON Strategy Co
TONX
$167M
$11K ﹤0.01%
3
CYPH
2081
Cypherpunk Technologies Inc
CYPH
$63.5M
$10K ﹤0.01%
+1,150
New +$14K
ML
2082
DELISTED
MoneyLion Inc.
ML
$10K ﹤0.01%
+382
New +$17.5K
OIG
2083
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$10K ﹤0.01%
501
+250
+100% +$6.93K
AGTC
2084
DELISTED
Applied Genetic Technologies Corporation
AGTC
$9K ﹤0.01%
33,800
-500
-1% -$218
SABS icon
2085
SAB Biotherapeutics
SABS
$272M
$8K ﹤0.01%
1,100
AMPE
2086
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$8K ﹤0.01%
430
DRRX
2087
DELISTED
DURECT Corp
DRRX
$7K ﹤0.01%
1,137
+95
+9% +$579
PRQR icon
2088
ProQR Therapeutics
PRQR
$244M
$7K ﹤0.01%
10,000
TOON icon
2089
Kartoon Studios
TOON
$35.7M
$7K ﹤0.01%
1,100
-1,100
-50% -$8.1K
RNTX
2090
Rein Therapeutics
RNTX
$62.8M
$6K ﹤0.01%
1,500
ECOR icon
2091
electroCore
ECOR
$55.2M
$5K ﹤0.01%
904
FTFT icon
2092
Future FinTech Group
FTFT
$1.92M
$5K ﹤0.01%
+13
New +$4.86K
AIXC
2093
AIxCrypto Holdings Inc
AIXC
$13.4M
$5K ﹤0.01%
40
AMBR
2094
Amber International Holding Ltd
AMBR
$132M
$5K ﹤0.01%
1,447
ASXC
2095
DELISTED
Asensus Surgical, Inc.
ASXC
$5K ﹤0.01%
10,343
-3,000
-22% -$1.56K
NYMX
2096
DELISTED
Nymox Pharmaceutical Corp
NYMX
$5K ﹤0.01%
11,532
CRBP icon
2097
Corbus Pharmaceuticals
CRBP
$167M
$3K ﹤0.01%
508
KALA icon
2098
KALA BIO
KALA
$13.6M
$3K ﹤0.01%
5
+1
+25% +$785
COMS
2099
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$2K ﹤0.01%
250
-402
-62% -$5.39K
ADT icon
2100
ADT
ADT
$5.62B
-11,076
Closed -$68K

Similar funds

Kestra Advisory Services's Q3 2022 Portfolio in Review

As of Q3 2022, Kestra Advisory Services held 2,284 positions worth $9.34B, down 4% from $9.73B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Kestra Advisory Services's Q3 2022 filing shows 156 new, 1,074 increased, 823 reduced and 182 closed positions. Its largest new stake was US Treasury 2 Year Note ETF: 142,009 shares worth $6.99M. The largest sale was Alphabet (Google) Class A, an estimated $142M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

  • Kestra Advisory Services's largest Q3 2022 buy was US Treasury 2 Year Note ETF: 142,009 shares worth $6.99M.
  • Kestra Advisory Services added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $45.3M increase.
  • Kestra Advisory Services's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $142M.
  • Kestra Advisory Services fully exited Aurinia Pharmaceuticals in Q3 2022, selling an estimated $5.87M.
  • Kestra Advisory Services's ten largest holdings make up 16% of its $9.34B portfolio in Q3 2022.
  • Kestra Advisory Services opened 156 new positions and closed 182 in Q3 2022.
  • Kestra Advisory Services's portfolio value fell 4% quarter-over-quarter to $9.34B.

Based on Kestra Advisory Services's 13F filing for Q3 2022, filed 1 Nov 2022.